RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Related Posts
Dan Crowley, CEO of RemedyBio, to Speak at the 7th Annual Allogeneic Cell Therapies Summit 2025 in Boston
karlobrienMarch 31, 2025
RemedyBio CEO to Chair Single Cell Technologies Session at BiotechX
karlobrienSeptember 19, 2024